• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

Nanopath Awarded $4M Grant to Support Point-of-Care Molecular Diagnostics for Women’s Health

by Syed Hamza Sohail 05/22/2024 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print
Nanopath Awarded $4M Grant to Support Point-of-Care Molecular Diagnostics for Women's Health

What You Should Know:

–              Nanopath Inc., a point-of-care diagnostics company enabling high-quality molecular testing in minutes, announced today that it was awarded $4 million in federal funding.

–              The company was awarded a $3 million grant from the National Institutes of Health (NIH) and a $1 million grant from the National Science Foundation (NSF) to support continued research and development of the company’s point-of-care diagnostic platform for pelvic and gynecologic infections and diseases

Nanopath Secures Over $15 Million in Funding to Advance Women’s Health Diagnostics

Nanopath has been awarded two grants through the Small Business Innovation Research (SBIR) Program, a competitive and awards-based initiative designed to stimulate technological innovations developed by small businesses. These new grants increase the company’s total funding to over $15 million.

Nanopath is addressing well-documented disparities in women’s health, which is both underfunded and under-researched. The company is developing a novel diagnostic technology specifically designed to meet the needs of women, empowering them to take control of their health. Their low-cost, easy-to-use diagnostic platform aims to provide unparalleled access to clinically actionable molecular diagnostic information at the point-of-care.

The new funds will be used for core platform development, including the test consumable and readout instrumentation, as well as the analytical and clinical validation of their lead assay. Nanopath envisions this technology becoming the new standard of care for the characterization of pelvic and gynecologic infections.

Nanopath has already developed advanced prototypes of both its disposable test cartridge and benchtop readout instrument. The company is actively expanding its pipeline of test offerings through clinical collaborations with preeminent hospitals in New England.

Since raising a $10 million Series A in 2022, Nanopath has achieved several significant milestones. These include growing the team from 4 to 14 employees, receiving the 2022 American Association for Diagnostic and Laboratory Medicine (ADLM) Disruptive Technology Award, and having its founders recognized on the 2023 Forbes 30 Under 30 (Healthcare) list. Additionally, Nanopath introduced its Scientific Advisory Board, which is comprised of several influential scientists in the field of nanobiosensing.

“This funding is a tremendous vote of confidence in Nanopath’s ability to transform molecular diagnostics and enable providers to move away from the traditional view of disease-specific diagnostic testing, and towards patient-centric testing,” said Amogha Tadimety, Ph.D., co-founder and CEO of Nanopath. “The outcomes of this grant-funded work could lay the groundwork for a new era of clinically informative diagnostics at any site-of-care, changing the paradigm of women’s healthcare.”

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

Digital Health Funding Q3 2025: Choppy Undercurrents Beneath a Steady Surface

Featured Interview

ConcertAI VP Shares View on AI Hallucinations and the Fabricated Data Crisis in Scientific Publishing

Most-Read

Cleveland Clinic and Khosla Ventures Form Strategic Alliance to Accelerate Healthcare Innovation

Cleveland Clinic and Khosla Ventures Form Strategic Alliance to Accelerate Healthcare Innovation

Northwell Health Selects to Deploy Abridge’s Ambient AI Across 28 Hospitals

Northwell Health to Deploy Abridge’s Ambient AI Across 28 Hospitals

Omada Health Launches "Nutritional Intelligence" with AI Agent OmadaSpark

Omada Health Launches AI-Powered Meal Map to Transform Nutrition for Cardiometabolic Patients

From Overwhelmed to Optimized: How AI Agents Address Staffing Challenges and Burnout in Healthcare

From Overwhelmed to Optimized: How AI Agents Address Staffing Challenges and Burnout in Healthcare

Qualtrics Acquires Press Ganey Forsta for $6.75B to Create the Most Comprehensive AI Experience Platform

Qualtrics Acquires Press Ganey Forsta for $6.75B to Create the Most Comprehensive AI Experience Platform

Pfizer and Trump Administration Announce Landmark Agreement to Lower Drug Costs

Pfizer and Trump Administration Announce Landmark Agreement to Lower Drug Costs

KLAS Report: Epic's Native Ambient Speech Tool Reshapes Customer AI Strategies

KLAS Report: Epic’s Native Ambient Speech Tool Reshapes Customer AI Strategies

Epic Unveils MyChart Central and New APIs to Advance Interoperability at Open@Epic

Epic Outlines Roadmap for Next-Generation Data Sharing at Open@Epic

Epic Launches Comet: A New AI Platform to Predict Patient Health Journeys

Epic Launches Comet: A New AI Platform to Predict Patient Health Journeys

RevSpring to Acquire Kyruus Health, Creating a Unified Patient Experience

RevSpring to Acquire Kyruus Health, Creating a Unified Patient Experience

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Op-Ed Submission Guidelines
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |